Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndrome
NCT01629212 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2012-06-27
Summary
The purpose of this study was to compare the Efficacy and Safety of Tiropramide HCl and Octylonium bromide in the Treatment of Irritable Bowel Syndrome.
Conditions
- Irritable Bowel Syndrome
Interventions
- DRUG
-
Tiropramide HCl 100mg
- DRUG
-
Octylonium bromide 20mg
Sponsors & Collaborators
-
Daewoong Pharmaceutical Co. LTD.
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 20 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-12-31
- Primary Completion
- 2013-02-28
- Completion
- 2013-02-28
Countries
- South Korea
Study Locations
More Related Trials
-
The Effect of Probiotics on Symptoms and Intestinal Flora in Patients With Irritable Bowel Syndrome
NCT02108119 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-center Human Study to Evaluate the Efficacy and Safety of ®GI Flora in Subjects With Irritable Bowel Syndrome
NCT02419027 ·Status: UNKNOWN ·Phase: NA
-
Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide
NCT00584298 ·Status: COMPLETED ·Phase: PHASE1
-
Exploring the Mechanism of a Probiotic Combination VSL#3 in Irritable Bowel Syndrome
NCT00786123 ·Status: COMPLETED ·Phase: NA
-
Efficacy of a Probiotic Blend to Reduce Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome
NCT05819281 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
NCT01844180 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D
NCT06247046 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy of Hydrogen Breath Test in the Patients With Irritable Bowel Syndrome
NCT02242175 ·Status: UNKNOWN ·Phase: NA
-
Donor Selection for Faecal Microbiota Transplantation in Irritable Bowel Syndrome
NCT06171126 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Administration of a Molecular Complex of Resins, Polysaccharides and Polyphenols in Irritable Bowel Syndrome.
NCT05016024 ·Status: COMPLETED ·Phase: NA
-
Manipulation of Visceral Sensitivity and Immune System in IBS
NCT00418340 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome
NCT00385099 ·Status: COMPLETED ·Phase: PHASE2
-
12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT02320318 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Randomized, Double-blind, and Placebo-controlled Study on the Treatments of Irritable Bowel Syndrome
NCT01641224 ·Status: UNKNOWN ·Phase: NA
-
Effect of Antibiotic Pretreatment on the Efficacy of WMT in the Treatment of Irritable Bowel Syndrome
NCT06437041 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
NCT01887002 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation
NCT02082457 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome
NCT00316550 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Determine Efficacy of Probiotics in Irritable Bowel Syndrome
NCT02545413 ·Status: WITHDRAWN ·Phase: PHASE3
-
52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT02120027 ·Status: TERMINATED ·Phase: PHASE3
-
Effectiveness of Probiotics Stabilized With Cryoprotection Technology in Patients With Irritable Bowel Syndrome
NCT04206410 ·Status: COMPLETED ·Phase: NA
-
Changes of Microbiota in Irritable Bowel Syndrome Patients
NCT01679730 ·Status: UNKNOWN
-
Effect of Doxepin and Nortriptyline on Irritable Bowel Syndrome
NCT01268709 ·Status: COMPLETED ·Phase: PHASE2
-
Manipulation of Visceral Hypersensitivity With Probiotic Bacteria in Irritable Bowel Syndrome
NCT01139736 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients
NCT02254629 ·Status: COMPLETED ·Phase: PHASE1